In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation. We saw an official end to the COVID-19 pandemic public health emergency and unlocked the potential
The acceleration of pharmaceutical innovation in recent years has helped save and improve countless lives. At the same time, the vulnerability of supply chains — pharmaceutical and commercial — has become even more evident amid the COVID-19 pandemic. These are among the many reasons why today is both an exciting and challenging time to practice
The COVID-19 pandemic made the last year both an extraordinary and challenging time to work in health care. Development, distribution and administration of new vaccines, treatments and preventatives moved at a pace never before experienced. Pharmacists and other health care practitioners were called to the front lines of a mass vaccination effort, working to balance
2020 has been especially challenging, particularly for frontline health care workers like pharmacists. COVID-19 quickly evolved from a localized disease in one part of the world to a pandemic that, according to the Johns Hopkins Coronavirus Resource Center, has infected over 63 million people worldwide and killed over 1.4 million, as of December 1. We
This year marks an important milestone for USP — and the entire health care sector. As we celebrate our 200th anniversary and gear up for our 2020 Convention, it’s an appropriate time to look at the work we’ve done and what lies ahead of us. From new technologies such as digital therapeutics, immunotherapy and artificial
